Considering that ischemic conditions and brain infarcts may trigger LGMN activation [17], only brains from AD patients and control subjects with no clinical history of stroke, hypoxia or ischemia and absence of ischemic lesions, brain infarcts and cerebral amyloid angiopathy at neuropathology were selected for our study. The gene discussed is LGMN; the disease is Stroke.